Longitudinal patterns of penile <scp>human papillomavirus</scp> detection among Ugandan men: A prospective sampling study
Human papillomavirus (HPV) is a highly prevalent sexually transmitted infection, yet data on HPV dynamics in African male populations remain limited. We conducted a prospective study of 300 human immunodeficiency virus-negative, sexually active Ugandan men enrolled at circumcision and followed every 6 weeks for 6 months. Penile swabs were collected by clinical staff, and HPV DNA was detected using the Roche polymerase chain reaction-based linear array assay at six time points. We estimated both point and cumulative prevalence of any and high-risk HPV, and assessed empirical and bootstrapped absolute and relative differences to quantify bias from relying solely on baseline testing. The baseline prevalence of any HPV was 49.7%, increasing to 66.0% when cumulative results were considered. Among 27 men with swabs with amplifiable viral or cellular DNA at all six visits, 100% tested positive at least once. HPV detection was often transient: only 6.1% of men with any HPV were consistently positive at all visits. Men who were ever HPV positive reported a younger age at first sex and more sexual partners. Single-timepoint testing significantly underestimated HPV prevalence, with relative biases of 24.7% for any HPV and 40.3% for high-risk HPV. Bootstrap analyses showed that reducing absolute bias to below 5% required two visits for any HPV and three for high-risk HPV, whereas achieving relative bias below 5% required three and five visits, respectively. The results remained consistent in sensitivity analyses that excluded pre-circumcision visits. These findings highlight the limitations of cross-sectional HPV testing and emphasize the importance of repeated sampling for accurate surveillance and vaccine impact assessments in male populations.
Authors
- M. Grabowski (ORCID: https://orcid.org/0000-0002-8072-4919)
- Thomas C. Quinn (ORCID: https://orcid.org/0000-0002-0404-1315)
- Eshan U. Patel (ORCID: https://orcid.org/0000-0003-2174-5004)
- Xinyi Feng (ORCID: https://orcid.org/0000-0001-5960-1028)
- Molly R. Petersen
- Ronald Moses Galiwango (ORCID: https://orcid.org/0000-0003-3702-5722)
- Aaron A.R. Tobian (ORCID: https://orcid.org/0000-0002-0517-3766)
- Fred Nalugoda (ORCID: https://orcid.org/0000-0001-6119-9293)
- Andrew D. Redd (ORCID: https://orcid.org/0000-0003-4651-1423)
- Steven J. Reynolds (ORCID: https://orcid.org/0000-0002-5403-2759)
- Patti E. Gravitt (ORCID: https://orcid.org/0009-0004-1443-152X)
- Godfrey Kigozi (ORCID: https://orcid.org/0009-0008-9142-6870)
Institutions
- Bloomberg (United States) (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Rakai Health Sciences Program (UG)
- National Institute of Allergy and Infectious Diseases (US)
- University of Baltimore (US)
Publication Details
- Journal
- International Journal of Cancer
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1002/ijc.70107
- Primary Topic
- Genital Health and Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
- NHLBI Division of Intramural Research